Keloid Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 995136|Published date: 03 December, 2024
Keratoconus Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 577666|Published date: 03 December, 2024
Keratitis Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 920521|Published date: 03 December, 2024
Kaposi’s Sarcoma Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 573597|Published date: 03 December, 2024
Isovaleric Acidemia Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 586510|Published date: 03 December, 2024
Ischemia Reperfusion Injury Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 200125|Published date: 03 December, 2024
Irritable Bowel Syndrome (IBS) Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 721935|Published date: 03 December, 2024
Intratumoral Cancer Therapies Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 292554|Published date: 03 December, 2024
Intraocular Lymphoma Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 506336|Published date: 03 December, 2024
Intracranial Aneurysms Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 426769|Published date: 03 December, 2024
Inflammatory Bowel Disease Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 324605|Published date: 02 December, 2024
Interstitial Lung Disease Market Insight, Epidemiology, and Market Forecast 2024-2032
Pharmaceuticals
$4750|GR - 586807|Published date: 02 December, 2024